Propanc Biopharma, Inc. SEC filings PPCB
Propanc Biopharma, Inc. has 438 filings in SEC EDGAR's recent list, going back to Jun 23, 2011. Its latest annual report, Form 10-K, was filed on Sep 25, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (listing notice). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14C | Information statement | Oct 21, 2026 | Oct 20, 2026 |
| PRE 14C | Filing | Oct 8, 2026 | Oct 8, 2026 |
| DEF 14C | Information statement | Aug 21, 2026 | Aug 20, 2026 |
| PRE 14C | Filing | Aug 5, 2026 | Aug 4, 2026 |
| DEF 14C | Information statement | Mar 31, 2026 | Mar 31, 2026 |
| PRE 14C | Filing | Mar 20, 2026 | Mar 19, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 19, 2026 | Mar 19, 2026 |
| DEF 14C | Information statement | Dec 29, 2025 | Dec 29, 2025 |
| PRE 14C | Filing | Dec 10, 2025 | Dec 10, 2025 |
| DEF 14C | Information statement | Aug 22, 2024 | Aug 22, 2024 |
| PRE 14C | Filing | Aug 8, 2024 | Aug 8, 2024 |
| DEF 14C | Information statement | Oct 5, 2022 | Oct 5, 2022 |
| PRE 14C | Filing | Sep 23, 2022 | Sep 23, 2022 |
| DEF 14C | Information statement | Jun 9, 2022 | Jun 9, 2022 |
| PRE 14C | Filing | May 27, 2022 | May 27, 2022 |
| DEF 14C | Information statement | Aug 5, 2020 | Aug 5, 2020 |
| PRE 14C | Filing | Jun 11, 2020 | Jun 11, 2020 |
| DEF 14C | Information statement | Feb 19, 2020 | Feb 18, 2020 |
| PRE 14C | Filing | Feb 6, 2020 | Feb 6, 2020 |
| DEF 14C | Information statement | Mar 18, 2019 | Mar 18, 2019 |
| PRE 14C | Filing | Mar 7, 2019 | Mar 7, 2019 |
| DEF 14C | Information statement | Aug 28, 2018 | Aug 28, 2018 |
| PRE 14C | Filing | Aug 16, 2018 | Aug 16, 2018 |
| DEF 14C | Information statement | Dec 29, 2017 | Dec 29, 2017 |
| PRE 14C | Filing | Dec 13, 2017 | Dec 13, 2017 |
| DEF 14C | Information statement | Mar 13, 2017 | Mar 15, 2017 |
| PRE 14C | Filing | Mar 3, 2017 | Mar 3, 2017 |
| PRE 14C | Filing | Jun 25, 2015 | Jun 25, 2015 |
| DEF 14C | Information statement | Dec 18, 2014 | Dec 18, 2014 |
| PRE 14C | Form pre 14c | Nov 26, 2014 | Nov 26, 2014 |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PPCB (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Camberwell, Victoria, Australia
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1517681
- Former names
- Propanc Health Group Corp (until Apr 5, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.